Venous ultrasonography may be an extraneous step in the diagnosis of pulmonary embolism. A D-dimer test performed with multislice CT scan is no less sensitive than the two tests performed in combination with venous ultrasound of the leg, according to a study from Switzerland.
Venous ultrasonography may be an extraneous step in the diagnosis of pulmonary embolism. A D-dimer test performed with multislice CT scan is no less sensitive than the two tests performed in combination with venous ultrasound of the leg, according to a study from Switzerland.
Accepted diagnostic methods to detect PE include clinical probability assessment (CPA) followed by sequential diagnostic tests, such as D-dimer, ultrasound, and CT, according to Dr. Marc Righini of the Geneva University Hospital, first author of the study in the April 18 issue of The Lancet.
MSCT is replacing pulmonary angiography as imaging modality of choice for PE because of its ability to visualize the segmental and subsegmental vessels, he said.
Righini and colleagues drew their findings from a randomized controlled trial of 1819 outpatients with clinically suspected PE. The first 903 patients were assessed with CPA combined with D-dimer measurement and MSCT. The second strategy involving 916 patients was the same as the first but included venous ultrasonography of the leg.
Effectiveness of each method was assessed by calculating the three-month risk of recurrent deep vein thrombosis or PE in patients who were left untreated on the basis of having been excluded by either strategy.
The researchers found that the prevalence of PE was 20.6% in both groups: 186 in the D-dimer/CT group, and 189 in the D-dimer/CT/ultrasound group. Analysis of the remaining patients showed that the three-month risk of PE was 0.3% in both groups, again suggesting the two strategies were equally effective.
-By James Brice
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.